Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

This study has been completed.
Information provided by:
Abbott Identifier:
First received: November 2, 1999
Last updated: April 2, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)